PROS1 and influenza: A comparison of the immunogenicity levels between combined vaccine (mRNA-5), quadrivalent mRNA vaccine (mRNA-4), and SIIV showed that the fifth component in the mRNA-5 vaccine (mRNA encoding the SARS-CoV-2 S protein) does not affect the immunogenicity of the influenza components.